1.Detection of 13 mutations on the 6 exons related to G6PD deficiency
2.US patented Flow-through Hybridization Technology
3.Compatible for use with whole blood, cord blood, dried blood spot and amniotic fluid samples
4.Include amplification control (IC) and hybridization control (Biotin) for monitoring of the entire detection process
Advantage
1.Rapid and accurate identification of mutations related to G6PD deficiency in one single test
2.Easy to operate with 1 hour hands-on time, result available within 3 hours
3.Simple and direct result interpretation
4.Effective and cost-efficient
5.Able to differentiate homozygous/ heterozygous carrier